Skip to main content

Table 2 CRPC patient characteristics and disease profiles

From: Treatment patterns and characteristics of European patients with castration-resistant prostate cancer

Characteristic

Total (n = 1405)

Age, years

70.8 (69.5–71.5)

Time since initial PC diagnosis, years

3.1 (2.6–3.9)

Karnofsky performance score at diagnosis, % patients

 

≥50

98%

≥70

89%

≥90

57%

Gleason score

7

Life expectancy, years

73.2 (67.0–72.3)

Current/ex-smokers, %

35 (26–45)

Receiving treatment for current disease, %

36 (26–44)

Family history of prostate cancer, %

10 (8–14)

Body mass index, kg/m2

25.8 (25.2–26.5)

Number of comorbidities

1.8 (1.7–2.2)

Surgical procedures, %:

 

 Radical prostatectomy

28

 TURP

12

 Pelvic lymph node dissection

7

  1. Data are mean (range) unless otherwise indicated.